ATE168135T1 - Diagnose von retinoblastoma - Google Patents

Diagnose von retinoblastoma

Info

Publication number
ATE168135T1
ATE168135T1 AT89902154T AT89902154T ATE168135T1 AT E168135 T1 ATE168135 T1 AT E168135T1 AT 89902154 T AT89902154 T AT 89902154T AT 89902154 T AT89902154 T AT 89902154T AT E168135 T1 ATE168135 T1 AT E168135T1
Authority
AT
Austria
Prior art keywords
retinoblastoma
diagnosis
methods
patients
polypeptide
Prior art date
Application number
AT89902154T
Other languages
English (en)
Inventor
Thaddeus P Dryja
Stephen Friend
David W Yandell
Original Assignee
Massachusetts Eye & Ear Infirm
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye & Ear Infirm, Whitehead Biomedical Inst filed Critical Massachusetts Eye & Ear Infirm
Application granted granted Critical
Publication of ATE168135T1 publication Critical patent/ATE168135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89902154T 1988-01-21 1989-01-23 Diagnose von retinoblastoma ATE168135T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14652588A 1988-01-21 1988-01-21
CA000588929A CA1340483C (en) 1988-01-21 1989-01-24 Diagnosis of retinoblastoma

Publications (1)

Publication Number Publication Date
ATE168135T1 true ATE168135T1 (de) 1998-07-15

Family

ID=25672399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89902154T ATE168135T1 (de) 1988-01-21 1989-01-23 Diagnose von retinoblastoma

Country Status (7)

Country Link
EP (1) EP0398955B1 (de)
JP (1) JP3163090B2 (de)
AT (1) ATE168135T1 (de)
AU (1) AU3038189A (de)
CA (1) CA1340483C (de)
DE (1) DE68928728T2 (de)
WO (1) WO1989006703A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US5858771A (en) * 1987-08-31 1999-01-12 The Regents Of The University Of California Products and methods for controlling the suppression of the neoplastic phenotype
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
US5998134A (en) * 1987-10-15 1999-12-07 The Regents Of The University Of California Retinoblastoma gene-cancer suppressor and regulator
DE69019410T2 (de) * 1989-03-31 1995-10-05 Canji Inc Retinoblastoma-Genprodukt-Antikörper und deren Verwendungen.
IE20010427A1 (en) * 1990-04-10 2003-03-05 Canji Inc Gene therapy for cell proliferative diseases
KR970005049B1 (ko) * 1990-07-16 1997-04-11 더 리젠츠 오브 더 유니벌시티 오브 캘리포니아 바쿨로비루스 발현 시스템, 이 벡터 시스템을 포함하는 이종성 무척추동물 숙주세포, 상기 시스템에 의해 생산되는 가용성의 정제된 야생형 망막아세포종 폴리펩티드 및 이 폴리펩티드의 생산 방법
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
US5759803A (en) * 1992-05-13 1998-06-02 Dana-Farber Cancer Institute Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
ZA946595B (en) * 1993-09-03 1996-02-28 Res Dev Foundation Mutants of the retinoblastoma and P53 genes and uses thereof
AU7834994A (en) * 1993-09-13 1995-04-03 Canji, Inc. Therapeutic use of the retinoblastoma susceptibility gene product
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US5545527A (en) 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
DE19653445C1 (de) * 1996-03-26 1997-12-11 Razvan T Dr Med Radulescu Peptide mit antineoplastischen Eigenschaften
CA2251691A1 (en) * 1996-03-26 1997-10-02 Razvan T. Radulescu Peptides with antiproliferative properties
JP2002509707A (ja) * 1998-03-31 2002-04-02 ジェンザイム・コーポレーション 肺腫瘍細胞を同定するための組成物および方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
GB8712646D0 (en) * 1987-05-29 1987-07-01 Clayton Found Res Structural evidence

Also Published As

Publication number Publication date
JPH04501951A (ja) 1992-04-09
WO1989006703A1 (en) 1989-07-27
EP0398955A1 (de) 1990-11-28
DE68928728D1 (de) 1998-08-13
EP0398955A4 (en) 1992-12-16
EP0398955B1 (de) 1998-07-08
JP3163090B2 (ja) 2001-05-08
AU3038189A (en) 1989-08-11
CA1340483C (en) 1999-04-06
DE68928728T2 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
ATE168135T1 (de) Diagnose von retinoblastoma
DK47588A (da) Forloeberprotein for apc-polypeptid, dna koderende for dette samt anvendelse af dna og af proteinet til diagnose
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
ATE358176T1 (de) Menschliche dnase
DE3788839D1 (de) Kapazitiver Messanordnung zur Bestimmung von Kräften und/oder Drücken.
DE68903884D1 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
NO160114C (no) Blanding for bruk ved ekstern paavisning og lokalisering av blodpropp.
DE3671834D1 (de) Knochennagel zur versorgung von oberarmfrakturen.
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
DE3576853D1 (de) Ultraschall-koagulationsanzeiger und methode zum nachweis des eintretens von koagulation.
DK100985A (da) Dna, der koder for human tumornecrosefaktor, samt humant tumornecrosefaktor-polypeptid og fremgangsmaader til fremstilling heraf
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE69729954D1 (de) Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
EP0209543A4 (de) Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren.
NO883834L (no) Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
DE69734890D1 (de) Rdgb-proteine
NO883626D0 (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
ATE530651T1 (de) Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
NO864742D0 (no) Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
DE3778375D1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties